Risk of congenital malformation following first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort
Lunedì 19 giugno 2023
ca. 1 min. di lettura
Journal and Affiliations:
Clinical Microbiology and Infection, 19 giugno 2023
Andrea Papadia, Ginecologia e ostetricia, EOC, Lugano
Maria Luisa Gasparri, Ginecologia e ostetricia, EOC, Lugano
Morena Antonilli, Ginecologia e ostetricia, EOC, Lugano
Christian Polli, Ginecologia e ostetricia, EOC, Lugano
Edoardo Taddei, Ginecologia e ostetricia, EOC, Lugano
Tags:
congenital anomaly
COVID-19
pregnancy
pregnant women
SARS-CoV-2
teratogenicity
vaccine
Authors:
Andrea Papadia
Christian Polli
Edoardo Taddei
Maria Luisa Gasparri
Morena Antonilli